Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study

NCT05149248 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

6000

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Cervix

Interventions

BIOLOGICAL: Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine]
BIOLOGICAL: Two dose
OTHER: Control group
BIOLOGICAL: 2 dose vaccination over 6 month

Sponsor

Instituto Nacional de Salud Publica, Mexico

Collaborators

[object Object]
[object Object]